AMAG Pharma (AMAG) – Major News
-
AMAG Pharma (AMAG) Misses Q2 EPS, Revs
-
AMAG Pharma (AMAG) Reports Q1 Loss of $0.72/sh
-
AMAG Pharma (AMAG) Reports Q4 Loss of $5.89/Share
-
AMAG Pharma (AMAG) Misses Q3 EPS by 4c
-
FDA AdCom Votes to Pull AMAG Pharma's (AMAG) Makena from Market in Mixed Vote
-
AMAG Pharma (AMAG) Posts Wider Q2 Loss
-
AMAG Pharma (AMAG) Reports Q1 Loss of $3.54/Share
-
AMAG Pharma (AMAG) Posts Smaller Q4 Loss
-
AMAG Pharma (AMAG) Posts Q3 Loss of $1.88/Sh
-
AMAG Pharma (AMAG) Misses Q2 EPS by 21c
-
AMAG Pharma (AMAG) Reports Q1 Loss Per Share of $1.59, Raises FY Revenue Guidance
-
AMAG Pharma (AMAG) Posts Q4 EPS of $0.10 on Tax Reform Gain
-
AMAG Pharma (AMAG) Reports Q3 Loss of $4.31/Share
-
AMAG Pharma (AMAG) Posts Q2 Loss of $0.40
-
AMAG Pharma (AMAG) Posts Q1 Loss of $1.06, Sales Miss Views
-
AMAG Pharma (AMAG) Reports Q4 Loss of $0.31
-
AMAG Pharma (AMAG) Offers Q4 and FY17 Guidance
-
AMAG Pharma (AMAG) Tops Q3 EPS by 31c
-
AMAG Pharma (AMAG) Tops Q2 EPS by 25c
-
AMAG Pharma (AMAG) Misses Q1 EPS by 17c; Reiterates Outlook
-
AMAG Pharma (AMAG) Tops Q4 EPS by 13c
-
AMAG Pharma (AMAG) Misses Q3 EPS by 16c; Boosts FY15 Outlook
-
AMAG Pharma (AMAG) Misses Q2 EPS by 1c
-
AMAG Pharma (AMAG) to Acquire Cord Blood Registry in $700M Deal
-
AMAG Pharma (AMAG) Tops Q1 EPS by 29c; Boosts FY15 Revenue Outlook
-
AMAG Pharma (AMAG) Misses Q4 EPS Views
-
AMAG Pharma (AMAG) Prelim. Q4, FY14 Revs Outlook Outpaces; Issues Strong FY15 Guidance
-
AMAG Pharma (AMAG) Reports Q3 EPS of 6c
-
AMAG Pharma (AMAG) to Acquire Lumara Health in $675M + Milestones Deal
-
AMAG Pharmaceuticals, Inc. (AMAG) Tops Q2 EPS by 2c
-
AMAG Pharmaceuticals, Inc. (AMAG) Posts Q4 Loss of 17c/Share; Updates Outlook
-
AMAG Pharmaceuticals (AMAG) Post Smaller Q3 Loss, Sees Higher FY Revs
-
AMAG Pharmaceuticals, Inc. (AMAG) Tops Q2 EPS by 8c
-
AMAG Pharmaceuticals, Inc. (AMAG) Misses Q4 EPS by 10c; Reaffirms FY13 Rev Outlook
-
AMAG Pharma (AMAG) Reports Q3 Loss of 19c/Share; Updates Feraheme Revs Outlook
-
AMAG Pharmaceuticals, Inc. (AMAG) Reports Q2 EPS of $0.15
-
AMAG Pharmaceuticals, Inc. (AMAG) Tops Q4 EPS by 25c
-
AMAG Pharmaceuticals (AMAG) Hires Jefferies To Enhances Shareholder Value
-
AMAG Pharmaceuticals, Inc. (AMAG) Posts Narrower than Expected Q3 Loss; CEO Pereira Resigns
-
MSMB Capital Offers to Acquire Amag Pharmaceuticals (AMAG) for $18/Share
-
AMAG Pharmaceuticals (AMAG) Posts Narrower than Expected Q2 Loss
-
AMAG Pharmaceuticals, Inc. (AMAG) Misses Q1 EPS by 3c
-
AMAG Pharmaceuticals (AMAG) Tops Q4 EPS by 10c
-
AMAG Pharma (AMAG) Reports Smaller-Than-Expected Loss; Revs Light
-
AMAG Pharmaceuticals (AMAG) Reports Large Q1 Loss; Revenues Light
-
AMAG Pharma (AMAG) Posts Q4 Loss of $1.07, Narrower than Views
-
AMAG Pharma (AMAG) Posts Q3 Loss of $1.29
-
AMAG Pharma (AMAG) Reports In-Line Q2 Loss of $0.55
-
AMAG Pharmaceuticals (AMAG) Announces FDA Approval of Feraheme
-
AMAG Pharmaceuticals (AMAG) Misses Q1 EPS by 25c
Back to AMAG Stock Lookup